Covered recipient · General Payments record
JILLIAN H FRIEDER
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$12,082.47
- Reported across 207 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,541.59 | 32 |
| Education | $109.93 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $377.49 | 5 |
| Amgen Inc. | $357.81 | 8 |
| Regeneron Healthcare Solutions, Inc. | $208.96 | 2 |
| ABBVIE INC. | $199.56 | 5 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $142.15 | 2 |
| ConvaTec Inc. | $122.57 | 1 |
| GENZYME CORPORATION | $83.95 | 3 |
| Lilly USA, LLC | $53.31 | 2 |
| E.R. Squibb & Sons, L.L.C. | $34.11 | 2 |
| Almirall LLC | $29.56 | 1 |
| Galderma Laboratories, L.P. | $28.84 | 2 |
| UCB, Inc. | $13.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.61 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103755475 | CMS |
| ABBVIE INC. | $119.38 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103755477 | CMS |
| ABBVIE INC. | $32.40 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103755479 | CMS |
| ABBVIE INC. | $8.80 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103755481 | CMS |
| ABBVIE INC. | $18.37 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103755483 | CMS |
| Almirall LLC | $29.56 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120639228 | CMS |
| Amgen Inc. | $20.34 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117254895 | CMS |
| Amgen Inc. | $7.10 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117254897 | CMS |
| Amgen Inc. | $134.78 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117254901 | CMS |
| Amgen Inc. | $13.48 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117254899 | CMS |
| Amgen Inc. | $135.30 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117254903 | CMS |
| Amgen Inc. | $30.84 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117254905 | CMS |
| Amgen Inc. | $8.00 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117254907 | CMS |
| Amgen Inc. | $7.97 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117254909 | CMS |
| ConvaTec Inc. | $122.57 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373990 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.11 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101515522 | CMS |
| E.R. Squibb & Sons, L.L.C. | $21.00 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101515647 | CMS |
| Galderma Laboratories, L.P. | $15.22 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145298002 | CMS |
| Galderma Laboratories, L.P. | $13.62 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145298004 | CMS |
| GENZYME CORPORATION | $33.20 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139920048 | CMS |
| GENZYME CORPORATION | $25.10 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139920064 | CMS |
| GENZYME CORPORATION | $25.65 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139920080 | CMS |
| Lilly USA, LLC | $25.20 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135064227 | CMS |
| Lilly USA, LLC | $28.11 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135023996 | CMS |
| PFIZER INC. | $119.60 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131320341 | CMS |
| PFIZER INC. | $6.00 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131697497 | CMS |
| PFIZER INC. | $118.11 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131838328 | CMS |
| PFIZER INC. | $15.27 | 07/22/2024 | Education | Undisputed | 01/23/2026 | 1131672961 | CMS |
| PFIZER INC. | $118.51 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131905904 | CMS |
| Regeneron Healthcare Solutions, Inc. | $114.30 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114050830 | CMS |
| Regeneron Healthcare Solutions, Inc. | $94.66 | 09/18/2024 | Education | Undisputed | 01/23/2026 | 1114050832 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $22.34 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152161032 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $119.81 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152161030 | CMS |
| UCB, Inc. | $13.21 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143247612 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.